Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard D. Homesley, MD
Gynecologic Oncology Network
Study Chair - Paula M. Fracasso, MD, PhD
Washington University Siteman Cancer Center
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- New England Medical Center Hospital
Boston, Massachusetts, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States
- Brookview Research, Inc.
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2000
- Primary completion
- 31 Aug 2005
- Completion
- —
- Last update posted
- 10 Jun 2013
- Registered enrollment
- —
- Registry id
- NCT00005861
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.